+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

AngioDynamics Inc (ANGO) - Financial and Strategic SWOT Analysis Review

  • PDF Icon

    SWOT Analysis

  • 52 Pages
  • May 2024
  • GlobalData
  • AngioDynamics
  • ID: 1322317
AngioDynamics Inc (ANGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by the analyst to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

AngioDynamics Inc (AngioDynamics) designs, manufactures and markets minimal invasive and image-guided therapeutics and diagnostic devices. Its product portfolio encompasses vascular products, radiofrequency ablation and NanoKnife systems, vascular access products, angiographic products and accessories, products for dialysis, angioplasty, drainage, thrombolysis and embolization, besides venous products and renal therapy products. The company’s products find application in interventional radiology, interventional cardiology, and minimally-invasive diagnosis and treatment of cancer and peripheral vascular disease. It sells its products through direct sales force in the US and through a network of distributors outside the US, which include Latin America Europe, Asia, and others. AngioDynamics is headquartered in Latham, New York, the US.

AngioDynamics Inc Key Recent Developments

  • Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
  • Oct 04, 2023: AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
  • Jun 09, 2023: Merit Medical acquires AngioDynamics’ catheter portfolio and biopsy system
  • Apr 13, 2023: AngioDynamics and Cardiva expand partnership to bring life-saving products to more patients in Europe

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table of Contents

Section 1 - About the Company
  • AngioDynamics Inc - Key Facts
  • AngioDynamics Inc - Key Employees
  • AngioDynamics Inc - Key Employee Biographies
  • AngioDynamics Inc - Major Products and Services
  • AngioDynamics Inc - History
  • AngioDynamics Inc - Company Statement
  • AngioDynamics Inc - Locations And Subsidiaries
  • Head Office
  • Other Locations & Subsidiaries
Section 2 - Company Analysis
  • Company Overview
  • AngioDynamics Inc - Business Description
  • Business Segment: Med Device
  • Overview
  • Performance
  • Business Segment: Med Tech
  • Overview
  • Performance
  • Geographical Segment: International
  • Performance
  • Geographical Segment: The US
  • Performance
  • R&D Overview
  • AngioDynamics Inc - Corporate Strategy
  • AngioDynamics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • AngioDynamics Inc - Strengths
  • AngioDynamics Inc - Weaknesses
  • AngioDynamics Inc - Opportunities
  • AngioDynamics Inc - Threats
  • AngioDynamics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • AngioDynamics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • AngioDynamics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • AngioDynamics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Jan 05, 2024: AngioDynamics Reports Fiscal Year 2024 Second Quarter Financial Results; Revises Fiscal Year 2024 Guidance
  • Oct 04, 2023: AngioDynamics Reports Fiscal Year 2024 First Quarter Financial Results; Reaffirms Fiscal Year 2024 Guidance
  • Jun 09, 2023: Merit Medical acquires AngioDynamics’ catheter portfolio and biopsy system
  • Apr 13, 2023: AngioDynamics and Cardiva expand partnership to bring life-saving products to more patients in Europe
  • Mar 30, 2023: AngioDynamics announces exciting new partnership with Minimax Medical
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About the Analyst
  • Contact the Publisher
  • Disclaimer
List of Tables
  • AngioDynamics Inc, Key Facts
  • AngioDynamics Inc, Key Employees
  • AngioDynamics Inc, Key Employee Biographies
  • AngioDynamics Inc, Major Products and Services
  • AngioDynamics Inc, History
  • AngioDynamics Inc, Other Locations
  • AngioDynamics Inc, Subsidiaries
  • AngioDynamics Inc, Key Competitors
  • AngioDynamics Inc, Ratios based on current share price
  • AngioDynamics Inc, Annual Ratios
  • AngioDynamics Inc, Interim Ratios
  • AngioDynamics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • AngioDynamics Inc, Medical Equipment, Deals By Type, 2018 to YTD 2024
  • AngioDynamics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • AngioDynamics Inc, Performance Chart (2019 - 2023)
  • AngioDynamics Inc, Ratio Charts
  • AngioDynamics Inc, Medical Equipment, Deals By Year, 2018 to YTD 2024
  • AngioDynamics Inc, Medical Equipment, Deals by Type, 2018 to YTD 2024

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Terumo Medical Corp
  • Merit Medical Systems Inc
  • Johnson & Johnson
  • Boston Scientific Corp
  • Cook Medical Inc
  • Total Vein Systems
  • Smiths Medical
  • Medtronic Plc
  • CR Bard Inc
  • Teleflex Inc